Skip to main content
Log in

Pharmacokinetics of midazolam in patients recovering from cardiac surgery

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The pharmacokinetics of midazolam has been studied in patients recovering from cardiac surgery, who required sedation for postoperative mechanical ventilation. Twelve males (mean age 64.5 years) with severe heart disease received an infusion of midazolam 15 mg·h−1 for 4 h, starting 1 to 3 h post surgery. Multiple blood samples were collected from each patient during the infusion and up to 48–93 h after it. The pharmacokinetic parameters of midazolam were determined using both moment analysis and the program NONMEM.

The average terminal half-life was 10.6 h. The prolonged elimination was mainly due to a decrease in its metabolic clearance (0.25 l·min−1).

The maintenance infusion dose of midazolam in such patients should be reduced. The time to recovery after stopping an infusion depends upon the amount of drug in the body at that time and a simulation of the plasma concentrations after various infusion regimens suggests that recovery will be delayed after prolonged (>48 h) administration of midazolam to these patients. However, after shorter infusions (<12 h), redistribution of the drug away from the site of action was still occurring and recovery would be expected to be relatively rapid.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Harper KW, Collier PS, Dundee JW, Elliott P, Halliday NJ, Lowry KG (1985) Age and nature of operation influence the pharmacokinetics of midazolam. Br J Anaesth 57: 866–871

    Google Scholar 

  2. Greenblatt DJ, Locniskar A, Ochs HR, Lauven PM (1981) Automated gas chromatography for studies of midazolam pharmacokinetics. Anesthesiology 55: 176–179

    Google Scholar 

  3. Greenblatt DJ, Abernethy DR, Locniskar A, Harmatz JS, Limjuco RA, Shader RI (1984) Effect of age, gender, and obesity on midazolam kinetics. Anesthesiology 61: 27–35

    Google Scholar 

  4. Smith MT, Eadie MJ, O'Rourke T (1981) The pharmacokinetics of midazolam in man. Eur J Clin Pharmacol 19: 271–278

    Google Scholar 

  5. Allonen H, Ziegler G, Klotz U (1981) Midazolam kinetics. Clin Pharmacol Ther 30: 653–661

    Google Scholar 

  6. Shapiro JM, Westphal LM, White PF, Sladen RN, Rosenthal MH (1986) Midazolam infusion for sedation in the intensive care unit: Effect on adrenal function. Anesthesiology 64: 394–398

    Google Scholar 

  7. Byatt CM, Lewis LD, Dawling S; Cochrane GM (1984) Accumulation of midazolam after repeated dosage in patients receiving mechanical ventilation in an intensive care unit. Br Med J 289: 799–800

    Google Scholar 

  8. Byrne AJ, Yeoman PM, Mace P (1984) Accumulation of midazolam in patients receiving mechanical ventilation [letter]. Br Med J 289: 1309

    Google Scholar 

  9. Oldenhof H, de Jong M, Steenhoek A, Janknegt R (1988) Clinical pharmacokinetics of midazolam in intensive care patients, a wide interpatient variability? Clin Pharmacol Ther 43: 263–269

    Google Scholar 

  10. Ha HR, Funk B, Maitre PO, Zbinden AM, Follath F, Thomson DA (1988) Measurement of midazolam in plasma from hospitalized patients as measured by gas liquid chromatography with electron capture detection. Clin Chem 34: 676–679

    Google Scholar 

  11. Sheiner LB, Rosenberg B, Melmon K (1972) Modelling of individual pharmacokinetics for computer aided dosage. Comput Biomed Res 5: 441–459

    Google Scholar 

  12. Kanto JH (1985) Midazolam the first water-soluble benzodiazepine. Pharmacotherapy 5: 138–155

    Google Scholar 

  13. Vozeh S, Katz G, Steiner V, Follath F (1982) Population pharmacokinetic parameters in patients treated with oral mexiletine. Eur J Clin Pharmacol 23: 445–451

    Google Scholar 

  14. Maitre PO, Vozeh S, Heykants J, Thomson DA, Stanski DR (1987) Population pharmacokinetics of alfentanil: The average dose-plasma concentration relationship and interindividual variability in patients. Anesthesiology 66: 3–12

    Google Scholar 

  15. Jusko WJ (1986) Guidelines for collection and analysis of pharmacokinetic data. In: Evans WE, Schentag JJ, Jusko WJ (eds) Applied pharmacokinetics. Applied Therapeutics Inc, San Francisco, pp 9–54

    Google Scholar 

  16. Westphal LM, Cheng EY, White PF, Sladen RN, Rosenthal MH, Sung ML (1987) Use of midazolam infusion for sedation following cardiac surgery. Anesthesiology 67: 257–262

    Google Scholar 

  17. Crevoisier C, Ziegler WH, Eckert M, Heizmann P (1983) Relationship between plasma concentration and effect of midazolam after oral and intravenous administration. Br J Clin Pharmacol 16: 51S-61S

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maitre, P.O., Funk, B., Crevoisier, C. et al. Pharmacokinetics of midazolam in patients recovering from cardiac surgery. Eur J Clin Pharmacol 37, 161–166 (1989). https://doi.org/10.1007/BF00558225

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00558225

Key words

Navigation